D.E. Shaw & Co’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.09M | Buy |
+608,280
| New | +$7.09M | 0.01% | 1243 |
|
2024
Q1 | – | Sell |
-41,743
| Closed | -$205K | – | 3102 |
|
2023
Q4 | $205K | Sell |
41,743
-89,526
| -68% | -$439K | ﹤0.01% | 2679 |
|
2023
Q3 | $715K | Buy |
131,269
+43,321
| +49% | +$236K | ﹤0.01% | 2188 |
|
2023
Q2 | $590K | Sell |
87,948
-139,781
| -61% | -$938K | ﹤0.01% | 2287 |
|
2023
Q1 | $2.01M | Buy |
227,729
+111,547
| +96% | +$985K | ﹤0.01% | 1862 |
|
2022
Q4 | $888K | Buy |
116,182
+57,498
| +98% | +$439K | ﹤0.01% | 2489 |
|
2022
Q3 | $418K | Sell |
58,684
-97,500
| -62% | -$694K | ﹤0.01% | 2945 |
|
2022
Q2 | $1.26M | Buy |
156,184
+23,981
| +18% | +$194K | ﹤0.01% | 2562 |
|
2022
Q1 | $1.84M | Buy |
+132,203
| New | +$1.84M | ﹤0.01% | 2489 |
|
2020
Q3 | – | Sell |
-19,068
| Closed | -$923K | – | 2554 |
|
2020
Q2 | $923K | Buy |
+19,068
| New | +$923K | ﹤0.01% | 1947 |
|
2020
Q1 | – | Sell |
-27,456
| Closed | -$821K | – | 2639 |
|
2019
Q4 | $821K | Buy |
+27,456
| New | +$821K | ﹤0.01% | 1998 |
|